Blood group does not correlate with disease severity in patients with Fabry disease (α-galactosidase A deficiency)
- 31 December 2003
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 31 (3) , 324-326
- https://doi.org/10.1016/s1079-9796(03)00163-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseasesJournal of Lipid Research, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001
- Blood group B glycosphingolipids in α-galactosidase deficiency (Fabry disease): influence of secretor statusBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
- Different phenotypic expression of fabry disease in female monozygotic twinsJournal of Inherited Metabolic Disease, 1991
- NATURE'S TRANSPLANT IN FABRY'S DISEASEThe Lancet, 1979
- Neurological manifestations of fabry disease in female carriersAnnals of Neurology, 1978
- Characterization of a Blood Group B Glycolipid, Accumulating in the Pancreas of a Patient with Fabry's DiseasePublished by Elsevier ,1973
- Fabry's Disease: Alpha-Galactosidase DeficiencyScience, 1970